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Summary
Accurate chromosome segregation relies upon a mitotic
checkpoint that monitors kinetochore attachment toward
opposite spindle poles before enabling chromosome
disjunction [1]. The MPS1/TTK protein kinase is a core
component of the mitotic checkpoint that lies upstream of
MAD2 and BubR1 both at the kinetochore and in the
cytoplasm [2, 3]. To gain insight into the mechanisms
underlying the regulation of MPS1 kinase, we undertook
the identification of Xenopus MPS1 phosphorylation sites
by mass spectrometry. We mapped several phosphoryla-
tion sites onto MPS1 and we show that phosphorylation
of S283 in the noncatalytic region of MPS1 is required for
full kinase activity. This phosphorylation potentiates
MPS1 catalytic efficiency without impairing its affinity for
the substrates. By using Xenopus egg extracts depleted
of endogenous MPS1 and reconstituted with single point
mutants, we show that phosphorylation of S283 is essential
to activate the mitotic checkpoint. This phosphorylation
does not regulate the localization of MPS1 to the kineto-
chore but is required for the recruitment of MAD1/MAD2,
demonstrating its role at the kinetochore. Constitutive
phosphorylation of S283 lowers the number of kineto-
chores required to hold the checkpoint, which suggests
that CDK-dependent phosphorylation of MPS1 is essential
to sustain the mitotic checkpoint when few kinetochores
remain unattached.
Results and Discussion
Phosphorylation of S283 Is Essential for Full MPS1
Kinase Activity
Analysis of Xenopus MPS1 electrophoretic mobility reveals
a slower migration in mitotic compared to interphase
extracts. Phosphatase treatment abolishes this mobility shift,
showing that MPS1 is strongly phosphorylated during mitosis
and to a lesser extent during interphase (Figure 1A). In the
presence of ATP, recombinant wild-type (WT) but not
kinase-dead (KD) MPS1 also showed retarded electropho-
retic mobility and autophosphorylation onto tyrosine and
threonine (Figure 1B), suggesting that MPS1 autophosphory-
lation activity contributes to its phosphorylation pattern. We
sought to identify MPS1 phosphorylation sites by mass spec-
trometry. In total, we could count up to 27 phosphorylation*Correspondence: ariane.abrieu@crbm.cnrs.frsites, out of which six were unambiguously identified (see
Table S1 available online). Along with the latter ones, we
selected five more sites on the basis of their conservation
between human and Xenopus MPS1 to be individually muta-
genized into nonphosphorylable alanines (Figure 1C). Single-
point mutants were translated into Xenopus egg extracts
depleted from endogenous MPS1, immunoprecipitated, and
tested for kinase activity in vitro by using MPS1 or myelin
basic protein (MBP) as substrates (Figure 1D). Three of these
mutants (S283A, T697A, and T707A) were found deficient to
phosphorylate MBP, similarly to a kinase-dead (KD) version
of MPS1 (D685A). We individually mutagenized each of these
three phospho-sites into phosphorylation-mimicking amino
acids (aspartate or glutamate). Remarkably, whereas both
S283D and S283E mutations restored full MPS1 kinase
activity, T697D, T697E, T707D, and T707E did not. This
demonstrates that the defect observed in S283A mutant
truly reflects a lack of phosphorylation. Although the intensity
of MPS1-S283A autophosphorylation signal is weaker than
that of WT-MPS1, the retarded electrophoretic mobility
is very close to WT-MPS1. It is therefore likely that the
efficiency of MPS1-S283A autophosphorylation activity is
diminished, but not abolished (compare migration delay for
autophosphorylation of S283A, T697A, T707A, and KD
mutant). Indeed, quantification of MPS1 kinase activities
(Figure 1E) indicates that although MPS1-S283A retains less
than 10% of its activity toward the exogenous substrate
MBP, roughly 60% of its autophosphorylation activity is
maintained.
We then compared the kinetic parameters of recombinant
MPS1 kinase toward two substrates: one short peptide that
we designed after determining a MPS1 substrate consensus
sequence (unpublished data), and the C-terminal domain of
Cenp-E (tail) that we characterized as being heavily phosphor-
ylated by MPS1 in vitro (Figure 1F) [4]. As shown in Figure 1G,
the Kmparameter was not significantly different betweenwild-
type and S283A or S283D MPS1 mutants, with either type of
substrate. However, for both types of substrates, the maximal
velocity of phosphorylation by S283A-MPS1 was diminished
2- to 3-fold, when compared toWTor S283D-MPS1 (Figure 1F).
Calculation of the kcat/Km parameter confirmed that the
enzyme efficiency was diminished 2- to 3-fold in S283A-
MPS1 versus S283D or WT-MPS1 (Figure 1G). This shows
that the phosphorylation of MPS1 at S283 does not modulate
the affinity of MPS1 for these substrates, but increases its
catalytic efficiency.
Because it was proposed that the dimerization of MPS1
could increase its kinase activity [5], we tested whether muta-
tions at S283 affected dimerization of recombinant MPS1.
To this end, we immunoprecipitated full-length MPS1 with
an antibody directed against its C-terminal peptide and
tested its interaction with the noncatalytic N-terminal domain
(aa 1–542). As shown in Figure 1H, all full-lengthMPS1 proteins
(wild-type, kinase-dead, S283A, or S283D mutants) were
capable of interacting with the N-terminal domain of MPS1 in
this assay. This suggests that the phosphorylation of MPS1
at S283 does not interfere with MPS1 dimerization to increase
MPS1 catalytic efficiency.
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Figure 1. Phosphorylation of MPS1 at S283 Potentiates MPS1 Catalytic Efficiency
(A) Retarded mobility of MPS1 from mitotic extract (ME) or interphase extract (IE) compared to mitotic extracts treated with lambda phosphatase (ME+l)
detected by protein immunoblot with the anti-MPS1-DNT serum.
(B) WT-MPS1 but not KD-MPS1 autophosphorylates in the presence of ATP on both tyrosine and threonine, which promotes retarded in-gel mobility, as
detected by protein immunoblot.
(C) Scheme of the phosphorylation sites mutated in this study.
(D) MPS1 single-point mutants were translated in mitotic extracts depleted from endogenous MPS1 and immunoprecipitated to measure their kinase
activity with MBP or MPS1 autophosphorylation as substrates, in the presence of g-[33P]ATP. Samples were then analyzed by SDS-PAGE and autoradiog-
raphy. The amount of immunoprecipitated MPS1 is evaluated by protein immunoblot after lambda phosphatase treatment to prevent retarded in-gel
mobility of the phosphorylated MPS1.
(E) Quantification of MPS1 kinase activity of S283, T676, and T686 mutants bearing alanine, aspartate, or glutamate substitutions, toward MBP or MPS1
autophosphorylation, as described in (D). The error bars represent the deviation from the mean from three independent experiments.
(F) The kinetic parameters of MPS1WT, S283A, or S283Dmutants weremeasured against varying concentrations of a 13-mer peptide (0, 5, 10, 20, 30, 40, 50,
80, 100 mM) or the polypeptide Cenp-E Tail (0, 1, 2, 3, 4, 6, 8, 10, 15 mM), in the presence of 50 nM of recombinant MPS1 enzymes. The data from three inde-
pendent experiments were plotted in Graph Pad Prismwith theMichaelis-Menten equation to extract the affinity (Km) and themaximal velocity (Vmax) of the
enzyme.
(G) Values of Km are expressed as the mean 6 the standard error of the mean (SEM). The kcat (Vmax/[MPS1]) and kcat/Km values are also indicated.
(H) Recombinant WT, S283A, S283D, or KD-MPS1were incubated with N-ter MPS1 for 20 min in XB buffer. Themixture was immunoprecipitated with MPS1
C-ter antibody, treatedwith lambda phosphatase, washed with XB, and loaded onto SDS-PAGE for visualization of MPS1 interaction by protein immunoblot
with the antibody directed against MPS1 N-terminal domain.
See also Table S1.
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290Phosphorylation of MPS1 at S283 Is Essential to Recruit
MAD1 and MAD2 at the Kinetochore and to Activate
the Mitotic Checkpoint
To determine whether these phosphorylations play a role
during checkpoint signaling, we used a checkpoint activity
assay in Xenopus egg extracts. In this system, the spindle
checkpoint can be activated by the depolymerization of
microtubules by nocodazole in the presence of a chromosome
concentration (9,000 nuclei/ml), which mimics the nucleocyto-
plasmic ratio of somatic cells [6]. Under these conditions,kinetochore-dependent signaling prevents APC/CCDC20 acti-
vation, thereby maintaining high CDK1 activity, as assessed
by measuring histone H1 phosphorylation. Because MPS1
kinase activity is essential to the mitotic checkpoint, its deple-
tion prevents the maintenance of the mitotic state, which is
restored if the extract is reconstituted with wild-type, but
not kinase-dead, MPS1 [2] (Figures 2A and 2B). With this
assay, we showed that all MPS1 mutants with impaired
kinase activity (S283A, T697A, T697D, T697E, T707A, T707D,
and T707E) are defective for checkpoint signaling, whereas
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Figure 2. S283 Phosphorylation of MPS1 Is Essential to Recruit MAD2 at the Kinetochore and to Activate the Mitotic Checkpoint
(A) Control or MPS1-depleted extracts were reconstituted with buffer (Ø), in-extracto-translated WT, KD, S283A, S283D, S283E, T697A, T697D, T697E,
T707A, T707D, or T707E-MPS1. Purified sperm heads (9,000/ml) and nocodazole are added to Xenopus egg extracts to activate the mitotic checkpoint. Acti-
vation of the checkpoint is scored by measuring CDK1 activity at 0, 30, or 60 min (min.) after release of the CSF arrest upon addition of 0.5 mMCaCl2. CDK1
activity is scored in the presence of purified histone H1 and g-[33P]ATP. Reaction products were analyzed by SDS-PAGE and autoradiography.
(B) The amount of endogenous and mutated MPS1 in the corresponding extracts is evaluated by protein immunoblot with the anti-MPS1-DNT serum.
(C) Control or MPS1-depleted extracts were reconstituted with buffer (Ø), recombinant WT, KD, S283A, or S283E-MPS1. Thirty minutes after activating the
checkpoint with purified sperm heads (9,000/ml) and nocodazole, the extracts were assayed for MPS1, MAD1, or MAD2 immunofluorescence. Chromatin
visualized with DAPI and MPS1/MAD1 costaining or MAD2 staining were merged.
Scale bar represents 5 mm. See also Figures S1 and S2.
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Figure 3. CDK1 Directly Phosphorylates MPS1
at S283
(A) Phosphospecific antibody raised against
S283 (pS283) detects MPS1 in protein immuno-
blot from mitotic extracts (ME), MPS1-depleted
extracts reconstituted with in-extracto-trans-
lated WT or KD-MPS1 and mitotic extracts in
which the checkpoint is activated (MEC). On the
contrary, pS283 antibody does not detect MPS1
from mitotic extracts treated with lambda phos-
phatase (ME+l), interphase extracts (IE), or
extracts depleted from MPS1 (Ø), even if recon-
stituted with in-extracto-translated S283A-
MPS1. The total amount of MPS1 is detected by
protein immunoblot with MPS1 antibody. The
asterisk indicates a contaminant.
(B) Time course of mitotic extract treated with
U0126 (0.4 mM) to inhibit MAPK kinase, RO3306
(0.4 mM) to inhibit CDK1 or CaCl2 (0.5 mM) to
promote exit from metaphase. Samples were
evaluated by protein immunoblot at the indicated
time points in minutes (min.) with the indicated
antibodies and by autoradiography to score for
CDK1 activity with histone H1 as a substrate in
the presence of g-[33P]ATP.
(C) Time course of interphase extracts treated
with cyclin A in the presence of cycloheximide
to promote CDK1, but not MAPK activity, and
analyzed as in (B).
(D) S283 phosphorylation onto recombinant KD-
MPS1 is lost upon treatment with lambda phos-
phatase (MPS1+l). After this treatment, KD-
MPS1 was immunoprecipitated to wash out the
phosphatase and incubated with ATP alone or
in the presence of CDK1 or MAPK. Both kinases
can phosphorylate recombinant KD-MPS1 as
shown by the incorporation of g-[33P], but only
CDK1 promotes phosphorylation of MPS1 at
S283, as detected by the phosphospecific anti-
body.
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292both phospho-mimicking catalytically active mutants (S283D
and S283E) restore MPS1 mitotic checkpoint function. As ex-
pected, kinase-activity-proficient phosphorylation mutants
(S7A, S156A, Y245A, S409A, Y485A, S703A, and S864A)
were all competent to reconstitute checkpoint signaling
(Figure S1), except for the S844A mutant, which was
previously shown to be defective in kinetochore recruitment
[7]. We conclude that phosphorylation of S283 is essential
for MPS1 kinase activity and function during checkpoint
signaling.
To determine the mechanism by which MPS1 mutants
compromised the spindle checkpoint, we examined by immu-
nofluorescence the localization of MPS1 and recruitment of
checkpoint proteins MAD1 and MAD2 to the kinetochore. We
confirmed that in mock-depleted extracts, endogenous
MPS1, MAD1, and MAD2 are recruited to kinetochores,
whereas MAD1 and MAD2 are absent from kinetochores
depleted from MPS1 (Figure 2C). Adding back recombinant
WT-MPS1 restored MPS1, MAD1, and MAD2 colocalization
at the kinetochores. The KD-MPS1 mutant was found at kinet-
ochore but did not allow the recruitment of MAD1 and MAD2,
confirming that MPS1 kinase activity is required to recruit
MAD1 and MAD2. We found that lack of MPS1 phosphoryla-
tion at S283 did not prevent its own targeting to the kineto-
chore, but did impair MAD1 andMAD2 recruitment (Figure 2C).
On the contrary, phosphomimicking mutation S283D
promoted MAD1 and MAD2 recruitment. Phosphorylation of
MPS1 at S283 is therefore essential for the correct targetingof MAD1 and MAD2 at the kinetochore, a prerequisite to
checkpoint signaling.
To further show that the checkpoint proficiency of MPS1-
S283D was acting upstream of MAD2, we challenged the
checkpoint either by depletion of MAD2 or by addition of poly-
clonal antibodies directed against MAD2. In both cases,
perturbation ofMAD2 preventedMPS1-S283D from sustaining
the checkpoint (Figure S2). Addition of an excess of MAD2 is
known to overcome the loss of kinetochore-dependent
signaling [8]. We now show that MAD2 overexpression is still
able to sustain the checkpoint despite the presence of
MPS1-S283A (Figure S2). Altogether, these results show that
phosphorylation of MPS1 at S283 is acting upstream of MAD2.
CDK1 Phosphorylates MPS1 at S283
To further investigate the regulation of MPS1 by phosphoryla-
tion, we produced an antibody specific for phospho-S283. As
shown in Figure 3A, this antibody detects a protein in mitotic
extracts (ME), but not in interphase extracts (IE), or in mitotic
extracts treated with lambda phosphatase (ME+l) or depleted
from MPS1 (Ø), showing that it recognizes phosphorylated
MPS1 in mitosis. This antibody detects WT-MPS1 but not
S283A-MPS1, showing that it specifically recognizes the phos-
phorylated S283 onto MPS1. Interestingly, both WT and
KD-MPS1 are recognized by this phospho-specific antibody,
which demonstrates that S283 is not an autophosphorylation
site. Although specifically occurring in mitosis, phosphoryla-
tion at S283 is not dependent upon kinetochores, because
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Figure 4. Constitutive Phosphorylation of S283 Sustains the Checkpoint despite an Insufficient Number of Kinetochores
(A) Extracts were complemented with the indicated number of nuclei (9,000; 3,000; 1,000 or 0 per ml) in the presence of nocodazole. Timing of mitotic exit
upon calcium addition (0.5 mM) at the indicated time points was assessed in control or MPS1-depleted extracts reconstituted with WT, S283A, or S283D-
MPS1, by following CDK1 activity with histone H1 as a substrate in the presence of g-[33P]ATP. Samples were then analyzed by SDS-PAGE and autoradi-
ography.
(B)Model: Maximal APC/CCDC20 inhibition as a three-step process. (1) BubR1- andMAD2-dependent basal inhibition of the APC/CCDC20 is achieved from the
G2 phase onward. (2) Upon entry into mitosis, CDK1-dependent phosphorylation of MPS1 onto S283 potentiates its catalytic efficiency. This amplifies the
inhibition of the APC/CCDC20, also via a BubR1 and MAD2 dependent mechanism. (3) Part of hyperactive MPS1 is recruited to the kinetochore via the CPC
and Ndc80 complexes, up to saturation of the kinetochore binding sites. This promotes the recruitment of MAD1-C-MAD2 to the kinetochore and the subse-
quent conformational change of cytoplasmic O-MAD2 into soluble C-MAD2 (see text for more details).
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293the antibody signal is as strong in chromosome-free mitotic
extracts (ME) as in checkpoint competent extracts containing
a high chromosome number and nocodazole (MEC) (Fig-
ure 3A). Because S283 is followed by a proline, we sought to
test whether the two proline-directed kinases active in mitosis
(CDK1 and MAPK) could be responsible for the phosphoryla-
tion of that site. We thus monitored the disappearance of
S283 phosphorylation in mitotic extracts subjected to the
MAPK kinase inhibitor U0126 or the CDK1 inhibitor RO3306.
As shown in Figure 3B, although CDK1 inhibition rapidly abol-
ishes phosphorylation of S283, MAPK inhibition does not.
S283 dephosphorylation occurs rapidly during mitotic exit,
concomitantly with CDK1-cyclin inactivation, but before
MAPK dephosphorylation (Figure 3B, right: mitosis exit
induced by calcium addition).
Reciprocally, reactivation of CDK1 activity in interphase
extracts upon addition of cyclin A promotes phosphorylation
of MPS1 at S283, despite the lack of MAPK activity (Figure 3C).
These experiments (Figures 3B and 3C) were performed in
extracts that were not complemented with chromosomes,
showing again that phosphorylation at S283 occurs in the
cytoplasm.
Finally, whereas bothCDK1 andMAPKphosphorylateMPS1
in vitro as shown by incorporation of radioactive g-phosphate
onto KD-MPS1, only CDK1 promotes phosphorylation of the
S283 of MPS1 (Figure 3D). Altogether, these results show
that phosphorylation of MPS1 at S283 by CDK in the cyto-
plasm during mitosis is essential for checkpoint signaling.
Constitutive Phosphorylation of S283 Lowers the Number
of Kinetochores Needed to Hold the Checkpoint
In Xenopus egg extracts, the minimal number of unattached
kinetochores required to keep the metaphase-to-anaphase
transition on hold corresponds to 9,000 nuclei per ml. As shown
in Figure 4A, lowering this number of kinetochores 3-fold
prevents activation of the checkpoint in control or MPS1-
depleted extracts reconstituted with WT or S283A-MPS1. Onthe contrary, reconstitution of MPS1-depleted extracts with
S283D-MPS1 sustains the checkpoint despite dilution of the
normal kinetochore complement by three and to a lesser
extent by nine (Figure 4A). However, constitutive phosphoryla-
tion of MPS1 is not sufficient to halt the metaphase-to-
anaphase transition in the absence of kinetochore-dependent
signaling. This further shows that phosphorylation of MPS1 at
S283 potentiates checkpoint signaling.
In light of our findings, we thus propose that MPS1-depen-
dent inhibition of APC/CCDC20 is a three-step process
(modeled in Figure 4B). First, MAD2- and BubR1/BUB1B-
dependent basal inhibition of APC/CCDC20 is achieved during
G2 [3, 9]. Second, upon mitotic entry, CDK1-cyclin becomes
active and phosphorylates MPS1, thus raising its kinase
activity by at least 3-fold.We showed that this phosphorylation
occurs in the cytoplasm where it is also known that MPS1
promotes the association of MAD2 and BubR1 with CDC20
[3]. Third, upon assembly of the CPC complex and the core
kinetochore components from the Ndc80 complex, phospho-
activated MPS1 reaches the kinetochore [10–13]. At the
kinetochore, MPS1 promotes at least two key events: (1)
recruitment of MAD1-C-MAD2 and (2) recruitment of cytosolic
O-MAD2 that will be converted into C-MAD2 upon binding
onto MAD1-C-MAD2 [14, 15].
S283 residue is located in MPS1 N-terminal noncatalytic
domain, whose role in MPS1 structure and function is poorly
understood. Previous studies have shown that the N-terminal
domain (aa 1–301) targets MPS1 to kinetochores and that
phosphorylation of residues T12 and S15 is required for the
recruitment of MPS1 to the kinetochore [16–18]. However,
our immunofluorescence assay reveals that lack of phos-
phorylation at residue S283 does not significantly impair
MPS1 localization to kinetochores.We suggest that phosphor-
ylation at S283 is not likely to be a major MPS1-kinetochore
docking epitope but is required to amplify MPS1 kinase
activity. In the present study, we analyzed the lack of MPS1
phosphorylation at residues T697 and T707 that were
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294previously shown to be autophosphorylation sites required for
MPS1 full kinase activity in human cells [5, 18–21]. We also
found that T697A and T707A mutants lack kinase activity.
Phosphorylation-mimicking mutations at T697 partially re-
stored MPS1 autophosphorylation activity but not its kinase
activity toward MBP. On the contrary, T707D and T707E mu-
tants remained inactive toward both types of substrates. Fur-
thermore, all T697 and T707mutants compromised the spindle
checkpoint, in agreement with previous studies [5, 20].
Previous reportshaveshown thatCDK1activity is required to
restrain APC/C activity during mitotic checkpoint in
S. cerevisiae and vertebrates [22, 23]. In the present study,
we uncovered one main target of CDK1 during checkpoint
signaling. Phosphoproteomic studies of the human kinome
also found S281 of MPS1 (equivalent to Xenopus S283) to be
phosphorylated in vivo [24]. Interestingly, phosphorylation at
S281was found tobeupregulateduponmitoticentry, remained
stable during mitosis, and declined upon mitotic exit [25].
Neither the kinase responsible for S281 phosphorylation nor
the significance of this phosphorylation was described. These
observations are consistent with our findings of Xenopus
MPS1, suggesting that the control of MPS1 by CDK1 is
conserved among vertebrates. However, MPS1 might not be
the only target of CDK1 during checkpoint signaling. Indeed,
in S. pombe, Cdc2p was shown to act upstream of Bub1p in
the mitotic checkpoint [26]. In vertebrates, CDK1 phosphory-
latesCDC20,whichmightbe required tosustain thecheckpoint
[27], and CDK1-dependent phosphorylation of Borealin was
shown tobeessential to recruit theCPCat the kinetochore [28].
We favor a model in which inhibition of the APC/CCDC20 is
amplified upon entry into mitosis via CDK1-dependent phos-
phorylation of MPS1 (and possibly other substrates) via
kinetochore- and cytoplasmic-dependent mechanisms. This
amplification contributes to the maintenance of a threshold
of APC/CCDC20 inhibition capable of coping with progressive
attachment and biorientation of the chromosomes and
concomitant diminution of inhibitory signal emanating from
the kinetochores. This model agrees with the proposal that
the rate of MAD2 cycling on and off the kinetochore is not
consistent with inhibition of the whole cellular pool of the
APC/CCDC20 [29]. When all the kinetochores are being
attached, the level of cytoplasmic signal becomes insufficient
to inhibit the whole cellular pool of the APC/CCDC20, thus allow-
ing cyclin B degradation and lowering CDK activity. Reversion
of the CDK-dependent mechanism that we uncovered could
thus promote a rapid switch toward APC/CCDC20 full activation,
allowing the exquisite synchrony of sister chromatid separa-
tion upon checkpoint silencing.Experimental Procedures
Protein Expression
MPS1 phosphorylation-site mutations were introduced by PCR in pCS2-
MPS1 plasmid with the QuikChange Site-Directed Mutagenesis Kit (Strata-
gene). The corresponding mRNAs were transcribed with the mMessage
mMachine SP6 kit (Ambion) and translated in extracto. For the production
of N-terminal-6His-tagged XenopusMPS1 proteins via baculovirus expres-
sion system, MPS1-WT, KD, S283A, and S283D cDNAs were subcloned into
pFastBac-Htb plasmid (Invitrogen). Recombinant 6His-MPS1 proteins were
expressed in Sf9 cells according to the manufacturer’s instruction given in
the Bac-to-Bac Baculovirus Expression System (Invitrogen). In brief,
MPS1 proteins were expressed for 72 hr at 28C. Cells were collected by
centrifugation at 500 3 g, washed with PBS, disrupted by French press in
lysis buffer, and centrifugated at 40,000 rpm for 30 min. Supernatants
were incubated with Ni-Sepharose beads (GE Healthcare) for 1 hr at 4C.
After washes, 6His-MPS1 proteins were eluted with step gradient ofimidazole and dialyzed into Storage buffer (50 mM K-HEPES [pH 7.4],
200 mM NaCl, 2 mM MgCl2, 10% sucrose, 20% glycerol). 6His-MAD2 was
produced as described [8]. N-ter-MPS1 (aa 1–542) was subloned into
a pRSET vector, expressed in E. coli BL21, and purified with His-tag affinity.
GST-WT-MPS1 and GST-KD-MPS1 were produced and purified as
described [2]. Recombinant human cyclin A was produced as described
[30]. Cenp-E Tail was produced as described [4].
Antibodies
Anti-MPS1-DNT (domain N-terminal) and C-ter serums were generated as
described [2]. The anti-MPS1-DNT serum was used for protein immunoblot,
and the anti-C-ter-purified antibody was used to immunoprecipitate active
MPS1kinase. For immunofluorescence, the purifiedanti-MPS1-DNTwasbio-
tinylated as described [2]. MPS1-pS283 antibody was generated against
a phosphorylated peptide C-PVQPAT-pS-PDTRTR (residues 277–289). Anti-
Human cyclin A and anti-Xenopus cyclin B2 antibodies were prepared as
described [30]. The antibodies directed against MAD1 and MAD2 were
produced as described [11]. p42 MAPK phosphorylation was analyzed by
anti-phospho-p44/42-MAPK mouse monoclonal antibody (9106, Cell
Signaling). Phosphothreonine (71-8200) and phosphotyrosine (sc-7020) anti-
bodieswerepurchasedfromZymed(Invitrogen)andSantaCruz, respectively.
Phosphorylation-Site Mapping by Mass Spectrometry
Recombinant GST-MPS1-WT (4–30 mg) expressed via the baculovirus
system was incubated in MPS1-depleted Xenopus egg extracts and then
pulled down onto Glutathione-Sepharose beads. In parallel, endogenous
MPS1 was immunoprecipitated from Xenopus CSF extracts. Samples
were separated on a denaturating gel and colored with colloidal blue.
Digested peptides were identified by mass spectrometry after enrichment
of phosphopeptides on TiO2 microcolumns, as described elsewhere [31].
Xenopus Egg Extracts and Immunofluorescence
Xenopus were handled according to French legislation. Mitotic extracts
were prepared as described [8]. Interphase extracts were prepared from un-
fertilized Xenopus laid eggs and activated by adding ionophore A23187
(Sigma-Aldrich) to a final concentration of 2 ng/ml for 3–4 min and washed
with XB buffer in the presence of cycloheximide at a final concentration of
0.1 mg/ml. To activate the mitotic checkpoint, CSF-arrested egg extracts
were incubated with sperm nuclei (9,000/ml extracts) for 10 min and incu-
bated for additional 20–30min with 10 mg/ml of nocodazole at room temper-
ature. To monitor activation of the mitotic checkpoint, the extracts were
driven into interphase by the addition of calcium chloride to a final concen-
tration of 0.5 mM, and samples of 1 ml of extracts were taken at the indicated
time points for histone H1 kinase assays. Immunodepletion was performed
for 30min at room temperature withmagnetic dynabeads-protein A coupled
to the corresponding purified antibodies. For reconstitution experiments, in
extracto translation of mRNA was performed in CSF-arrested Xenopus egg
extracts immunodepleted from endogenous MPS1. In brief, extracts were
supplemented with 1/100 volume of 0.1 M DTT, 1/100 volume of RNA Guard
inhibitor (GE Healthcare) and incubated for 10 min at 10C. tRNA were
added to a final concentration of 0.1 mg/ml. For 100 ml of treated extracts,
10 ml of reticulocyte lysate (Promega), 2 ml of 0.5 M creatine phosphate,
and 1 ml of 0.1 M spermidine were added. Aliquots of the translations
were frozen in liquid nitrogen and stored at280C, thus allowing us to deter-
mine the protein yield by comparing endogenous and in-extracto-translated
MPS1 by protein immunoblot. Fresh extracts depleted from endogenous
MPS1 were then reconstituted with roughly equal amounts of in-extracto-
translated MPS1. Immunofluorescence was performed as described [2].
Images were captured with a Zeiss AxioimagerZ1 motorized microscope
and analyzed with the Metamorph software (Molecular Devices).
Kinase Assays
To test the kinase activity of in-extracto-translated MPS1 mutants, extracts
were incubated with Dynabeads-Protein A coupled to MPS1-Cter antibody.
Beads were washed and resuspended in 50 mM K-HEPES (pH 7.6). 10% of
immunoprecipitated MPS1 was used to evaluate the yield by protein immu-
noblot, whereas 45%was used tomeasure its autophosphorylation activity,
and the remaining 45% was used to measure its kinase activity in the pres-
ence of 0.5 mg/ml MBP. Phosphorylation experiments were performed in
the presence of phosphorylation buffer (50 mM K-HEPES [pH 7.6], 5 mM
MgCl2, 100 mM ATP, and 0.1 mCi/ml g-[
33P]ATP) during 15 min at room
temperature and stopped by adding Laemmli buffer. Samples were
analyzed by SDS-PAGE and autoradiography. For protein immunoblotting,
the beads were incubated with 40 units of lambda protein phosphatase
(NEB) for 1 hr shaking at 30C. Samples were transferred onto nitrocellulose
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295membrane and blotted with anti-MPS1-DNT serum. The kinetic parameters
of MPS1 were determined by using the indicated concentrations of peptide
(YDDDHTVWLWKKK) or Cenp-E tail (aa 2717–2954) substrates in the phos-
phorylation mix for 10 min. The experiment was stopped by loading the
samples onto P81 paper and washed for 1 hr in 0.8% phosphoric acid.
The cpm on dried P81 papers were measured with a scintillation counter
(Perkin Elmer). MPS1 autophosphorylation was determined by measuring
the phosphorylation in the absence of exogenous substrate and subtracted
from the experiments in the presence of added substrates. Data were fit to
the Michaelis-Menten equation to derive apparent Vmax and Km with the
Graph Pad Prism software. For histone H1 kinase assays, 1 ml of extract
was frozen in liquid nitrogen at the indicated time points. Extract samples
were thawed by the addition of H1 mix (0.15 mg/ml histone H1, 1 mM
beta-glycerophosphate, 10 mM MgCl2, 20 mM EGTA, 100 mM ATP,
0.1 mCi/ml g-[33P]ATP) and incubated for 10 min at room temperature. Reac-
tions were stopped by adding Laemmli buffer, loaded onto SDS-PAGE, and
analyzed by autoradiography. To test for direct phosphorylation of MPS1,
we immunoprecipitated recombinant GST-KD-MPS1 with MPS1-Cter anti-
body. One sample was taken for protein immunoblot, and the bulk was de-
phosphorylated with lambda phosphatase for 1 hr at 30C. Beads were
washed with 50 mM Tris-HCl (pH 7.4). Immunoprecipitated and dephos-
phorylated MPS1 was then incubated with phosphorylation buffers in the
presence of cyclin B1/CDK1 (NEB-P6020) or p42 MAPK (NEB-P6080). After
30 min of incubation at room temperature, reactions were loaded onto a de-
naturating gel and analyzed by autoradiography or protein immunoblot.
Supplemental Information
Supplemental Information includes two figures and one table and can be
found with this article online at doi:10.1016/j.cub.2011.12.048.
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